🏹 Active Trades
Loading...

πŸŒ… Dawn Watch: The East Stirs Before the West Awakens

❧ ❧ ❧

πŸŒ… Dawn Watch: The Fellowship of Record Highs Marches On

Good morning, market watchers. While most of you were dreaming of sugar plums and year-end bonuses, the Asian markets were busy doing their best impression of a confused orc patrol - wandering about without much direction but generally moving forward.

The Asian Chronicles

The Fellowship of Asian indices managed to edge higher overnight, following their American cousins who continue to set records with the persistence of Samwise Gamgee climbing Mount Doom. The S&P 500's latest record high has Asian traders acting like hobbits who've discovered second breakfast - cautiously optimistic but not entirely sure what comes next.

Of course, "mixed" appears to be the operative word here, which in trader-speak means "we have absolutely no idea what we're doing, but at least we're not falling off a cliff." The rupee decided to slip against the dollar faster than Boromir's resolve around the One Ring, as corporate dollar bids proved stronger than any uptick in regional peers. Apparently, even in the season of giving, the dollar remains the precious that everyone wants.

The Indian markets are particularly amusing this morning, with Gift Nifty movements apparently worthy of the same attention as Sauron's troop deployments. Eight key things changed overnight, they tell us - though I suspect most involve the same recycled observations about gold prices and GDP data that we've been hearing since the Second Age.

Today's European Quest

Looking ahead to European trading, we have the usual assortment of corporate news that reads like a fellowship meeting where everyone's speaking different languages. Novo Nordisk has won FDA approval for an oral Wegovy pill, because apparently we needed another way to make weight management as complicated as the Council of Elrond's decision-making process.

ExxonMobil continues its Ent-like resilience in soft commodity pricing - slow-moving but surprisingly durable. Meanwhile, Lululemon is being touted as having "limited downside, ample upside" for 2026, which sounds suspiciously like what every investment banker said about mortgage securities in 2007.

The IPO market is making noises about a "comeback tour" in 2025, with various companies filing documents faster than eagles carrying news to Gondor. Crypto companies have apparently "returned to the IPO model," which I interpret as "we've run out of other ways to separate investors from their gold."

The Wizard's Assessment

European traders should expect today what they've been getting all December: a market that moves like Treebeard making a decision - deliberate, occasionally surprising, but mostly just grinding forward on momentum. The shortened Christmas Eve session yesterday in the U.S. showed continued gains, suggesting this rally has more lives than a cat in Bag End.

However, beware the traditional year-end thinness. Light volume can make markets move like Gollum's mood swings - sudden, unpredictable, and often entirely divorced from underlying fundamentals.

The real question is whether this record-setting behavior continues into the New Year, or if we're witnessing the final charge of King ThΓ©oden - glorious but ultimately unsustainable without reinforcements from actual economic substance.

Keep your stop-losses closer than Frodo kept his mithril shirt. In markets as in Middle-earth, overconfidence in victory often precedes the most spectacular defeats.

Gandral the Grey, from the Tower of Market Watch

Gandral the Grey
Gandral the Grey

Wizard of ancient wisdom. Millennia of watching empires rise and fall inform his commentary on global finance and political folly.

This dispatch is provided for entertainment purposes only and does not constitute investment advice. Past performance of elven arrows hitting targets does not guarantee future returns.